Evidence map›Paper›PMID 34776218›Full record

ArticleMethods in enzymology2021

Characterization of the telomerase modulating activities of yeast DNA helicases.

David G Nickens, Matthew L Bochman

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David G NickensMolecular & Cellular Biochemistry Department, Indiana University, Bloomington, IN, United States.
Matthew L BochmanMolecular & Cellular Biochemistry Department, Indiana University, Bloomington, IN, United States. Electronic address: bochman@iu.edu.
Indiana University Bloomington · US

Funding

DNA helicases and associated factors in genome stabilityR35GM133437 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BOCHMAN, MATTHEW LINNE · 2019 to 2023
$2.4M
NIGMS NIH HHS R35 GM133437
6 · The paper itself

Abstract

Eukaryotes with linear chromosomes circumvent the end replication problem via the action of a specialized ribonucleoprotein reverse transcriptase known as telomerase. Cells lacking telomerase activity will senesce when their chromosome ends shorten to a critical length. In contrast, cancer cells can become immortalized by upregulating telomerase to lengthen telomeres during each cycle of DNA replication. Thus, the regulation of telomerase is critical for normal telomere homeostasis. Of the various known ways that telomerase activity is modulated in vivo, recent studies have demonstrated that DNA helicases are involved. In Saccharomyces cerevisiae, the Hrq1 and Pif1 helicases act in a pathway that regulates telomerase extension at telomeres and at DNA double-strand DNA breaks. In vitro analysis demonstrates that when these helicases are combined in reactions, they synergistically inhibit or stimulate telomerase activity depending on which helicase is catalytically active. Here, we describe the methods for the overproduction and purification of Hrq1 and Pif1. We also report the preparation of partially purified cell extracts with telomerase activity and how the effects of these helicase on telomerase activity can be assessed in vitro.

Indexed as

Saccharomyces cerevisiae ProteinsTelomeraseDNA HelicasesRecQ HelicasesSaccharomyces cerevisiaeTelomereTelomere HomeostasisDNA HelicasesHrq1 protein, S cerevisiaePIF1 protein, S cerevisiaeRecQ HelicasesSaccharomyces cerevisiae ProteinsTelomeraseDNA helicaseHrq1PIF1RecQTelomerase

Identifiers

PMID34776218
PMCPMC8978066
OpenAlexW3214601613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.